MedPath

Levetiracetam

These highlights do not include all the information needed to use LEVETIRACETAM safely and effectively. See full prescribing information for LEVETIRACETAM. Levetiracetam Injection for intravenous use. Initial U.S. Approval : 1999

Approved
Approval ID

a92107d6-5006-4f6a-ace8-6e18ab14677c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 9, 2011

Manufacturers
FDA

Nexus Pharmaceuticals Inc

DUNS: 620714787

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

LEVETIRACETAM

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code14789-400
Application NumberANDA090813
Product Classification
M
Marketing Category
C73584
G
Generic Name
LEVETIRACETAM
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJune 7, 2010
FDA Product Classification

INGREDIENTS (5)

SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
LEVETIRACETAMActive
Quantity: 100 mg in 1 mL
Code: 44YRR34555
Classification: ACTIM
SODIUM ACETATEInactive
Quantity: 1.6 mg in 1 mL
Code: 4550K0SC9B
Classification: IACT
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Levetiracetam - FDA Drug Approval Details